EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unraveling the Pathogenetic Potential and Immune Crosstalk of Yersinia spp. in Inflammatory Bowel Disease

Fattaneh Sabzehali iD, Verena Zerbato, Stefano Di Bella iD, Stefano Morabito, Mohammad Reza Zali iD, Abbas Yadegar iD

Journal of Immunology Research · 2026

DOI: 10.1155/jimr/2846665 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Fattaneh Sabzehali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical …. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Yersinia Infections, Yersinia enterocolitica, Yersinia. Die Arbeit nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Yersinia enterocolitica and Yersinia pseudotuberculosis have been identified as microbiological factors in the multifactorial pathophysiology of inflammatory bowel disease (IBD). Although conventionally associated with self‐limiting gastroenteritis, Yersinia has been increasingly investigated for its potential role in IBD, particularly in genetically predisposed individuals. Whether this reflects causality, opportunistic colonization, or secondary enrichment within inflamed tissue, however, remains unresolved. Polymerase chain reaction (PCR)‐based studies have detected Yersinia DNA in the intestinal tissues of patients with IBD, and epidemiological studies have suggested an association between prior Yersinia infection and an increased long‐term risk of disease. However, because most evidence is based on PCR detection, with limited culture‐based confirmation of viable organisms and infrequent sequencing of PCR amplicons, these findings do not establish active infection or a causal relationship. These pathogens exploit abnormalities in the epithelial barrier and compromised mucosal immunity through type III/VI secretion systems to disrupt host responses, activate inflammasomes, and induce pyroptosis. Polymorphisms in autophagy‐related genes, such as NOD2 and ATG16L1, impair pathogen clearance and increase susceptibility. While antibiotics continue to be effective against invasive diseases, the rise of resistance highlights the necessity for alternatives. Probiotic‐based strategies have demonstrated immunomodulatory, antimicrobial, and barrier‐protective effects in preclinical models, although their therapeutic efficacy in IBD requires further clinical validation. Comprehending Yersinia –host genetic interactions could facilitate precision diagnostics and microbiota‐targeted treatments in IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesYersinia InfectionsYersinia enterocoliticaYersiniaYersinia pseudotuberculosisHumansAnimalsHost-Pathogen InteractionsNod2 Signaling Adaptor ProteinIntestinal MucosaImmunity, Mucosal

Stichwörter der Autor:innen

Crohn’s diseaseYersinia enterocoliticaYersinia pseudotuberculosishost–pathogen interactioninflammatory bowel diseaseinnate immunityulcerative colitis

Substanzen

Nod2 Signaling Adaptor Protein

Autor:innen und Institutionen

  • Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.
  • Infectious Diseases Unit, Trieste University Hospital (ASUGI), Trieste, Italy.
  • Clinical Department of Medical, Surgical, and Health Sciences, Trieste University, Trieste, Italy, units.it.
  • Department of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Viale Regina Elena, 299, Roma 00161, Italy, iss.it.
  • Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.

ORCID-Profile: Fattaneh Sabzehali, Stefano Di Bella, Mohammad Reza Zali, Abbas Yadegar

Förderung

  • Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences

Zitieren

APA

Sabzehali, F., Zerbato, V., Bella, S. D., Morabito, S., Zali, M. R., & Yadegar, A. (2026). Unraveling the Pathogenetic Potential and Immune Crosstalk of Yersinia spp. in Inflammatory Bowel Disease. Journal of Immunology Research. https://doi.org/10.1155/jimr/2846665

Vancouver

Sabzehali F, Zerbato V, Bella SD, Morabito S, Zali MR, Yadegar A. Unraveling the Pathogenetic Potential and Immune Crosstalk of Yersinia spp. in Inflammatory Bowel Disease. Journal of Immunology Research. 2026. doi:10.1155/jimr/2846665

BibTeX
@article{Sabzehali2026,
  author = {Sabzehali, Fattaneh and Zerbato, Verena and Bella, Stefano Di and Morabito, Stefano and Zali, Mohammad Reza and Yadegar, Abbas},
  title = {Unraveling the Pathogenetic Potential and Immune Crosstalk of Yersinia spp. in Inflammatory Bowel Disease},
  journal = {Journal of Immunology Research},
  year = {2026},
  doi = {10.1155/jimr/2846665}
}
Kostenlos starten →